Weight Loss & GLP-1 FAQs

GLP-1 medication management at Balanced includes comprehensive lab monitoring that goes beyond the basic metabolic panel most prescribers check.

Baseline and periodic monitoring includes: comprehensive metabolic panel (kidney and liver function — GLP-1s are primarily eliminated renally), lipase and amylase (pancreatic enzymes — monitoring for pancreatitis risk), thyroid function (TSH, free T4 — GLP-1 receptor agonists carry a theoretical thyroid risk based on rodent studies), HbA1c and fasting glucose (tracking metabolic improvement), fasting insulin (measures insulin resistance improvement — often normalizes before blood sugar changes), lipid panel (GLP-1s frequently improve lipid profiles), inflammatory markers (hs-CRP — tracking systemic inflammation reduction that accompanies fat loss).

Additionally, Balanced monitors body composition (not just scale weight — preserving lean muscle mass during weight loss is critical), vitamin and mineral levels (rapid weight loss can deplete nutrients), and hormone levels (significant fat loss changes hormone metabolism — testosterone, estrogen, and thyroid may need adjustment).

This level of monitoring ensures safe, effective treatment and allows your provider to optimize your protocol as your body changes.

Medical Weight Loss →  ·  Services →

GLP-1 medications aren't restricted to clinically obese patients. At Balanced, candidacy is evaluated based on your overall metabolic health profile, body composition goals, and clinical presentation — not just BMI.

Patients who benefit from GLP-1 therapy beyond obesity include those with insulin resistance (even at a normal weight — 'metabolically unhealthy normal weight'), stubborn visceral fat that doesn't respond to diet and exercise, metabolic syndrome components (elevated triglycerides, high blood pressure, impaired fasting glucose), and patients seeking body composition optimization who have a moderate amount of fat to lose (20–40 lbs).

The key distinction: Balanced uses GLP-1 medications as part of a comprehensive metabolic optimization program, not as standalone weight loss drugs. This means concurrent attention to muscle preservation (protein targets, resistance training guidance), hormone optimization (thyroid, testosterone, cortisol), and metabolic health markers (insulin sensitivity, inflammatory markers).

Your provider evaluates whether GLP-1 therapy is clinically appropriate based on your labs, body composition, health history, and goals during consultation.

Medical Weight Loss →  ·  Contact →

The difference is clinical depth vs. transactional prescribing. Most telehealth GLP-1 companies follow a simple model: brief questionnaire, prescription, monthly shipment, minimal monitoring. You get the medication but not the medical care.

Balanced's approach includes comprehensive lab work before starting (metabolic panel, hormones, inflammatory markers, thyroid, insulin sensitivity — not just a questionnaire), physician-supervised dosing with regular adjustment based on labs and clinical response, concurrent hormone evaluation (significant weight loss changes testosterone, thyroid, and estrogen metabolism — if you don't monitor and adjust, you can end up hormonally depleted despite losing weight), body composition monitoring (ensuring you're losing fat, not muscle — scale weight alone is misleading), nutritional guidance and protein targets to preserve lean mass, and peptide support for recovery, metabolism, and tissue quality during rapid body composition change.

The practical outcome: patients who use Balanced's program lose fat while maintaining or building muscle, optimize their hormonal environment alongside weight loss, and have dramatically better long-term maintenance because the metabolic foundation is addressed — not just the appetite.

Medical Weight Loss →  ·  Services →

Semaglutide is the active molecule. Ozempic and Wegovy are Novo Nordisk's brand-name versions — Ozempic is FDA-approved for diabetes, Wegovy for weight loss. Compounded semaglutide contains the same active molecule but is produced by licensed compounding pharmacies rather than the original manufacturer.

Compounded versions exist because brand-name supply has been severely constrained, creating a legitimate clinical need. Under FDA regulations, compounding pharmacies can produce medications during documented shortages from licensed, inspected facilities.

Key differences: brand-name products undergo full FDA approval including clinical trials. Compounded versions are regulated by state pharmacy boards and may undergo different (though still rigorous) quality standards. Pricing is typically significantly lower for compounded versions.

At Balanced, all compounded semaglutide and tirzepatide are sourced from licensed U.S. sterile compounding pharmacies that operate under cGMP standards with third-party purity and potency testing. Your provider explains exactly what you're receiving and from which pharmacy. Transparency about sourcing is non-negotiable.

Weight Loss →  ·  Contact →

You can, but most patients on GLP-1s find their relationship with alcohol naturally changes. GLP-1 medications reduce the reward response to alcohol similarly to how they reduce food cravings — many patients report less interest in drinking and feeling the effects more intensely from smaller amounts.

Practical considerations: alcohol is calorie-dense (7 calories per gram) and provides zero nutritional value, working directly against weight loss goals. GLP-1 medications slow gastric emptying, which can intensify alcohol's effects — you may become intoxicated faster and experience more pronounced hangovers. The combination of GLP-1-induced nausea (especially during dose titration) and alcohol can increase GI discomfort.

The clinical guidance at Balanced: moderate alcohol consumption isn't contraindicated on GLP-1s, but awareness of changed tolerance is important. Many patients find that the reduced desire for alcohol is a welcome secondary benefit of treatment. For patients where alcohol was contributing to caloric excess, the reduced interest accelerates weight loss progress.

Weight Loss →  ·  Services →

Most weight loss programs focus on the medication — prescribe a GLP-1, monitor weight, refill. Balanced approaches weight loss as a metabolic restoration project where the medication is one tool within a comprehensive strategy.

The Balanced difference starts with diagnosis: comprehensive metabolic labs (fasting insulin, thyroid panel, sex hormones, inflammatory markers) identify why your metabolism is dysfunctional — not just that you need to lose weight. Many patients discover that hormonal imbalance, thyroid dysfunction, or insulin resistance has been the invisible barrier all along.

Treatment is multi-layered: GLP-1 medication (semaglutide or tirzepatide) addresses appetite and metabolic signaling. Hormone optimization (TRT, thyroid, women's HRT) restores the metabolic infrastructure. Peptide therapy (Tesamorelin for visceral fat, CJC-1295/Ipamorelin for body composition) adds targeted support. Nutrition guidance addresses the behavioral foundation. Body composition monitoring tracks fat loss and muscle preservation separately.

The goal isn't just a number on the scale — it's metabolic health restoration that produces sustainable body composition change.

Weight Loss →  ·  Services →

GLP-1 medications (semaglutide, tirzepatide) are appropriate for adults with BMI ≥30 (obesity) or BMI ≥27 with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea). However, at Balanced, candidacy assessment goes deeper than BMI.

Ideal candidates include patients who have tried diet and exercise without sustained success (indicating metabolic dysfunction rather than lack of effort), patients with insulin resistance or prediabetes (GLP-1s address the metabolic root cause), patients whose weight gain correlates with hormonal changes (menopause, andropause, thyroid dysfunction), and patients who are ready for a comprehensive approach (not just seeking a quick-fix injection).

Patients who may not be ideal candidates: those with personal or family history of medullary thyroid carcinoma or MEN2 syndrome (contraindicated), history of pancreatitis (relative contraindication), active eating disorders (GLP-1s can worsen disordered eating patterns), and patients seeking a standalone solution without willingness to address nutrition and lifestyle.

At Balanced, the initial consultation and comprehensive labs determine not just whether you qualify, but whether GLP-1 therapy is the right metabolic intervention for your specific situation.

Weight Loss →  ·  Contact →

Medical weight loss is a physician-supervised approach to weight management that goes beyond diet and exercise alone. It may include prescription medications, metabolic testing, hormone evaluation, and structured monitoring to address the biological factors driving weight gain — not just the behavioral ones.

At Balanced Aesthetics + Wellness, medical weight loss starts with comprehensive lab work to understand what's happening beneath the surface: hormone levels, thyroid function, insulin sensitivity, cortisol, inflammatory markers, and metabolic health indicators. That data determines your treatment plan — because two patients with the same weight loss goal can have completely different biological drivers.

Our programs may include GLP-1 medications (semaglutide or tirzepatide), supportive peptide therapy to preserve lean muscle, nutritional guidance, and ongoing monitoring with regular check-ins. This is a structured program with clinical oversight — not a prescription and a handshake.

The distinction between medical weight loss and commercial weight loss programs is the clinical foundation. We're not guessing what might work. We're testing, prescribing based on evidence, and tracking measurable outcomes.

Medical Weight Loss →  ·  Services →

GLP-1 medications are a class of drugs that mimic glucagon-like peptide-1, a hormone your body naturally produces to regulate appetite, blood sugar, and gastric emptying. When prescribed for weight management, they help reduce hunger, increase feelings of fullness, and improve metabolic signaling.

The two most commonly prescribed GLP-1 medications for weight loss are semaglutide (brand names Ozempic and Wegovy) and tirzepatide (brand names Mounjaro and Zepbound). Tirzepatide is technically a dual GIP/GLP-1 agonist, meaning it activates two receptor pathways instead of one.

GLP-1 medications were originally developed for type 2 diabetes management but showed significant weight loss effects in clinical trials — leading to dedicated weight management formulations. They work by signaling your brain to feel satisfied with less food and by slowing how quickly your stomach empties, which extends the feeling of fullness after meals.

At Balanced, GLP-1 medications are prescribed as part of a comprehensive metabolic program — never as a standalone prescription. We combine them with lab work, peptide support, nutritional guidance, and regular monitoring to maximize results while protecting your overall health.

Medical Weight Loss →  ·  Medical Weight Loss →

Semaglutide is a GLP-1 receptor agonist — it activates one hormonal pathway involved in appetite regulation and blood sugar control. Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates two pathways simultaneously, which is why clinical data has shown it may produce greater weight reduction in some patients.

In head-to-head clinical comparisons, tirzepatide has generally demonstrated higher average weight loss percentages than semaglutide at comparable treatment durations. However, individual response varies significantly — some patients respond better to semaglutide, others to tirzepatide. Biology matters more than averages.

The side-effect profiles are similar: nausea, particularly during dose escalation, is the most common for both. Tirzepatide's dual mechanism may produce different GI effects in some patients. Both require gradual dose titration to minimize side effects.

At Balanced, the choice between semaglutide and tirzepatide isn't made by trend or preference — it's made by your metabolic profile, treatment history, and how your body responds. Some patients start on one and switch to the other based on results and tolerability. Your provider guides that decision based on your labs and clinical response.

Medical Weight Loss →  ·  Medical Weight Loss →

Clinical trial data suggests tirzepatide produces higher average weight loss than semaglutide in head-to-head comparisons. But "better" depends on how your individual biology responds — and averages don't predict individual outcomes.

Some patients tolerate semaglutide better with fewer GI side effects. Others respond more strongly to tirzepatide's dual-receptor mechanism. Some patients who plateau on one medication see renewed progress when switching to the other. There's no universal winner.

The more important question than "which is better" is: what's actually driving your weight gain? If insulin resistance is a primary factor, tirzepatide's GIP pathway may offer additional metabolic benefit. If appetite suppression is the main need, both are effective. If hormonal imbalance is contributing, neither medication fully addresses the root cause without concurrent hormone optimization.

At Balanced, we don't default to one medication over the other. We look at your labs, your metabolic markers, your health history, and your goals — then prescribe accordingly. If the first choice isn't producing expected results, we adjust.

Medical Weight Loss →  ·  Medical Weight Loss →

The choice between tirzepatide and semaglutide should be made with your provider based on your metabolic labs, health history, and treatment goals — not based on social media trends or what worked for someone else.

Both medications are effective for weight management. Tirzepatide's dual GIP/GLP-1 mechanism may offer advantages for patients with significant insulin resistance, as the GIP pathway plays a role in glucose metabolism beyond what GLP-1 alone addresses. Semaglutide has a longer track record and extensive safety data.

Factors your provider considers: your baseline metabolic panel (insulin, A1c, fasting glucose), body composition, hormonal status, prior medication history, GI sensitivity, and your specific weight loss goals. Cost and availability may also play a role — the landscape for both medications continues to evolve.

At Balanced, we frequently see patients who've tried one medication through a telehealth company or their PCP and felt unsupported. The medication itself is only part of the equation. The program around it — labs, monitoring, peptide support, nutritional guidance — is what determines whether you get lasting results or just a temporary number on the scale.

Medical Weight Loss →  ·  Medical Weight Loss →

Semaglutide mimics GLP-1, a hormone your gut naturally produces after eating. It works through three primary mechanisms: it signals your brain's appetite center to reduce hunger, it slows gastric emptying so you feel full longer after meals, and it improves insulin signaling, which helps your body regulate blood sugar more effectively.

The appetite suppression is the most immediately noticeable effect — patients typically report a significant reduction in food cravings and a natural tendency to eat smaller portions without the willpower battle that characterizes most diets. The gastric emptying effect extends satiety, making it easier to go longer between meals without discomfort.

Semaglutide is administered as a once-weekly subcutaneous injection. Dosing starts low and gradually escalates over several weeks to minimize side effects — particularly nausea, which is most common during the titration period.

At Balanced, semaglutide is never prescribed in isolation. It's part of a metabolic program that includes baseline labs, hormone evaluation, supportive peptide therapy for muscle preservation, and regular monitoring. The medication resets your metabolic signaling; the program ensures you maintain that reset long-term.

Medical Weight Loss →  ·  Medical Weight Loss →

Tirzepatide activates two hormone receptors simultaneously: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism produces appetite suppression and improved metabolic signaling through two complementary pathways rather than one.

The GLP-1 component reduces appetite and slows gastric emptying — the same effects as semaglutide. The GIP component adds additional metabolic benefits: improved insulin sensitivity, enhanced fat metabolism, and potentially greater impact on visceral fat stores. Together, the dual pathway may produce more comprehensive metabolic improvement than GLP-1 alone.

Like semaglutide, tirzepatide is administered as a once-weekly subcutaneous injection with gradual dose escalation. The titration schedule helps your body adjust and minimizes GI side effects during the early phase.

The practical result for patients is often described as a quieting of the "food noise" — the constant mental chatter about eating, cravings, and willpower that makes weight management exhausting. When that signal quiets, patients can focus on building sustainable habits rather than fighting their biology.

Medical Weight Loss →  ·  Medical Weight Loss →

The most common side effects of semaglutide are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These are most pronounced during the dose escalation phase (the first several weeks) and typically improve as your body adjusts to the medication.

Nausea is the most frequently reported side effect and is dose-dependent — meaning it tends to occur when the dose increases and then stabilizes at each level. Eating smaller meals, avoiding high-fat foods, and staying hydrated can help manage it. Gradual titration is specifically designed to minimize this effect.

Less common side effects include fatigue, headache, dizziness, and injection-site reactions. Some patients report flu-like symptoms during the first day or two after injection — a low-grade achiness that typically resolves within 24–48 hours.

More serious but rare potential risks include pancreatitis, gallbladder issues, and thyroid-related concerns (a boxed warning exists regarding medullary thyroid carcinoma risk based on animal studies). These are discussed during your consultation, and your provider screens for risk factors before prescribing.

At Balanced, we monitor patients throughout their program and adjust dosing based on tolerability. The goal is therapeutic benefit with manageable side effects.

Medical Weight Loss →  ·  Medical Weight Loss →

Tirzepatide's side-effect profile is similar to semaglutide: the most common effects are gastrointestinal — nausea, vomiting, diarrhea, constipation, and decreased appetite. These are most noticeable during dose escalation and tend to improve as your body adapts.

Because tirzepatide activates two receptor pathways (GIP and GLP-1), some patients experience slightly different GI patterns compared to semaglutide. The intensity and duration of nausea may differ between the two medications for any given patient, which is one reason providers sometimes switch between them.

Other reported side effects include injection-site reactions, headache, fatigue, and acid reflux. More serious but rare risks — pancreatitis, gallbladder events, and thyroid considerations — are comparable to those seen with semaglutide.

At Balanced, side-effect management is built into the program. We start at the lowest effective dose and titrate gradually. If GI effects are disruptive, we can slow the escalation, hold at a lower dose, or switch medications. The program includes regular check-ins specifically to address tolerability.

Medical Weight Loss →  ·  Medical Weight Loss →

Nausea is the most common side effect during GLP-1 therapy, and there are several strategies that help. Eating smaller, more frequent meals rather than large portions reduces the demand on a stomach that's emptying more slowly. Avoiding high-fat and greasy foods during the first weeks of treatment helps significantly. Staying well-hydrated throughout the day is essential.

Timing matters too. Some patients find nausea is worse on injection day and the following day, then improves. Injecting in the evening so you sleep through the peak nausea window works for some. Others prefer morning injections so the effect is lighter by bedtime.

Gradual dose titration is the most important factor. Your provider escalates the dose in small increments over weeks, giving your body time to adapt at each level. If nausea is severe at a particular dose, we can hold at the lower dose longer before increasing — there's no mandatory escalation timeline.

At Balanced, we also support GLP-1 patients with peptide therapy that can help counterbalance the fatigue and low energy some patients experience alongside the GI effects. Keeping protein intake high and fiber consistent makes a meaningful difference in how you feel during the adjustment period.

Medical Weight Loss →  ·  Medical Weight Loss →

Muscle loss during rapid weight loss is a legitimate concern with GLP-1 medications — and it's one of the reasons Balanced takes a different approach than most prescribers.

When you lose weight quickly through significant calorie reduction — which GLP-1 medications facilitate through appetite suppression — your body can break down lean muscle tissue alongside fat, particularly if protein intake drops and resistance training isn't maintained. Studies have shown that a meaningful percentage of weight lost on GLP-1 therapy can come from lean mass rather than fat alone.

This is exactly why our gold standard approach pairs every GLP-1 prescription with supportive peptide therapy. Growth hormone secretagogues like CJC-1295/Ipamorelin help preserve lean muscle mass during active weight loss by supporting growth hormone levels that naturally decline when caloric intake drops. This combination allows patients to maintain energy, preserve muscle, and improve body composition — not just see a lower number on the scale.

Adequate protein intake (we typically recommend 0.7–1g per pound of lean body mass) and consistent resistance training are also critical components. At Balanced, your program includes guidance on both — not just the prescription.

Medical Weight Loss →  ·  Medical Weight Loss →

Because a GLP-1 medication alone solves the appetite problem but can create new ones — muscle loss, fatigue, bone density concerns, and metabolic rebound risk. Peptide therapy addresses all of these.

Our gold standard protocol pairs the GLP-1 (semaglutide or tirzepatide) with growth hormone secretagogue peptides that help preserve lean muscle mass during active weight loss. When your appetite drops significantly, your caloric intake drops, and without intervention, your body will catabolize muscle tissue alongside fat. Growth hormone support counteracts that by maintaining the anabolic signaling that protects lean mass.

Patients on the combined protocol consistently report maintaining their energy levels throughout the program — a common complaint with GLP-1 alone is fatigue and feeling drained, particularly in the first weeks. The peptide component helps maintain metabolic output even as food intake decreases.

This approach also sets up a better transition off the GLP-1 medication. Patients who preserve muscle during weight loss have a higher resting metabolic rate when they discontinue the medication, which significantly reduces the risk of weight regain. At Balanced, the goal isn't just weight loss — it's sustainable body composition change.

Medical Weight Loss →  ·  Peptide Therapy →

Most patients begin noticing appetite changes within the first 1–2 weeks of starting semaglutide, though meaningful weight loss typically becomes apparent over 4–8 weeks as the dose gradually escalates to therapeutic levels.

The dose titration process — starting low and increasing every 4 weeks — means you won't be at the full therapeutic dose immediately. Early weeks produce mild appetite suppression; the full effect builds as your dose increases. Significant weight loss typically accumulates over 3–6 months of consistent use at therapeutic doses.

Individual timelines vary based on starting weight, metabolic health, insulin resistance, hormonal factors, and how well you tolerate dose escalation. Patients with significant insulin resistance may see slower initial progress until their metabolic signaling improves.

At Balanced, we set expectations clearly: this is not a quick fix. The medication works gradually and consistently when combined with proper nutrition and activity. We track progress through regular weigh-ins, body composition measurements, and follow-up labs — not just the scale number.

Medical Weight Loss →  ·  Medical Weight Loss →

Weight loss outcomes vary significantly between individuals, and we don't promise specific numbers. What we can share is that clinical research on GLP-1 medications has demonstrated meaningful body weight reduction over 12–18 month treatment periods when combined with lifestyle modifications.

The amount you lose depends on multiple factors: your starting weight, metabolic health, hormonal balance, activity level, dietary adherence, the specific medication used, and whether you're also addressing underlying drivers like insulin resistance, cortisol elevation, or thyroid dysfunction.

At Balanced, we focus on body composition change — not just the scale. A patient who loses 30 pounds while preserving lean muscle has a fundamentally different outcome than one who loses 30 pounds but 40% of it is muscle. Our combined GLP-1 + peptide approach targets fat loss specifically while protecting the lean tissue that keeps your metabolism healthy.

We track progress with body composition measurements, lab work, and clinical assessments — not just weight. The goal is sustainable metabolic improvement, not a number that bounces back when you stop the medication.

Medical Weight Loss →  ·  Medical Weight Loss →

This is one of the most important questions patients should ask — and one that many GLP-1 prescribers don't adequately address.

When you discontinue a GLP-1 medication, the appetite suppression and gastric emptying effects gradually wear off over 2–4 weeks. Hunger returns to pre-treatment levels. Without a transition plan, many patients regain a significant portion of the weight they lost — research suggests up to two-thirds within the first year off medication.

This is why how you lose the weight matters as much as whether you lose it. Patients who preserved muscle mass during treatment (through peptide support and adequate protein) have a higher resting metabolic rate after discontinuation, which reduces the caloric surplus that drives regain. Patients who built sustainable eating habits and exercise routines during treatment have behavioral tools to maintain their results.

At Balanced, the transition off GLP-1 is a planned phase — not an abrupt stop. We gradually taper the dose, monitor your metabolic markers, and may continue peptide therapy during the transition to maintain lean mass. Some patients transition to a lower maintenance dose rather than full discontinuation. Your provider builds the exit strategy into your program from the beginning.

Medical Weight Loss →  ·  Medical Weight Loss →

Weight regain after discontinuing GLP-1 therapy is common when the medication is the only intervention — which is why Balanced doesn't prescribe GLP-1 as a standalone treatment.

The risk of regain depends on several factors: whether you preserved muscle mass during treatment, whether you addressed underlying metabolic drivers (insulin resistance, hormonal imbalance, cortisol), whether you built sustainable nutrition and exercise habits, and how you transitioned off the medication.

Our approach reduces regain risk in four specific ways. First, peptide therapy preserves lean muscle — more muscle means a higher metabolic rate after discontinuation. Second, comprehensive labs identify and address the metabolic drivers that caused the weight gain, so you're not just masking symptoms. Third, gradual dose tapering allows your body to readjust rather than experiencing an abrupt return of appetite. Fourth, ongoing support during the transition phase catches early signs of regain before it accelerates.

Some patients choose to remain on a low maintenance dose long-term — similar to how blood pressure medication is used continuously. That's a legitimate option we discuss during your program.

Medical Weight Loss →  ·  Medical Weight Loss →

Medical weight loss costs depend on which medication is prescribed, the dose, the duration of treatment, and what additional services are included in your program. At Balanced, we discuss full program pricing during your consultation after we've evaluated your labs and determined the appropriate protocol.

We take this approach because pricing a generic "weight loss program" without knowing your specific situation would be misleading. A patient on semaglutide alone has a different cost structure than someone on tirzepatide plus peptide support plus body composition tracking. Your program is built around your biology — and the pricing reflects that.

What we can say: investing in a medically supervised program with comprehensive monitoring, peptide support, and a planned transition strategy costs more than a telehealth app that sends you a prescription and a good luck email. The difference is outcomes — not just during treatment, but after.

We offer structured packages like Slim & Strong that bundle common service combinations at preferred pricing. Your provider walks you through options during the consultation so you can make an informed decision.

Medical Weight Loss →  ·  Slim And Strong →

Insurance coverage for GLP-1 medications varies significantly by plan, medication, and indication. Some insurance plans cover brand-name semaglutide (Wegovy) or tirzepatide (Zepbound) for weight management with specific BMI or comorbidity requirements. Many plans do not cover them for weight loss, or require extensive prior authorization.

Compounded GLP-1 medications — which are what many weight loss clinics, including Balanced, prescribe — are generally not covered by insurance because they are compounded formulations rather than brand-name products.

At Balanced, our medical weight loss program operates on a direct-pay model. This simplifies the process — no prior authorization delays, no insurance gatekeeping on your treatment decisions, and your provider prescribes based on what your labs indicate rather than what an insurer approves.

We understand cost is a factor, and we're transparent about pricing during the consultation. Our packages and memberships are designed to make ongoing treatment more accessible. The investment in a supervised program that includes labs, peptide support, and monitoring produces different results than a prescription alone — and the long-term health savings from sustainable weight management are substantial.

Medical Weight Loss →  ·  Memberships →

Compounded semaglutide is semaglutide prepared by a licensed compounding pharmacy rather than manufactured by the brand-name pharmaceutical company (Novo Nordisk). Compounding pharmacies create medications to specific prescriptions under FDA and state pharmacy board oversight.

The safety of compounded semaglutide depends entirely on the source. Compounded medications from licensed, verified U.S. compounding pharmacies are prepared under strict quality controls — including sterility testing, potency verification, and endotoxin screening. These are the pharmacies that legitimate medical practices use.

The concern — and it's a valid one — is that not all compounding pharmacies maintain the same standards, and the regulatory landscape for compounded GLP-1 medications continues to evolve. This is why your provider's sourcing matters. At Balanced, we source exclusively from pharmacies we've verified and trust.

The FDA has issued guidance on compounded GLP-1 medications, and the regulatory environment is active. We stay current on all compliance requirements and adjust our sourcing and prescribing practices accordingly. If you have questions about where your medication comes from, we're happy to discuss it transparently.

Medical Weight Loss →  ·  Medical Weight Loss →

Brand-name GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) are manufactured by large pharmaceutical companies, carry specific FDA approvals, and come in pre-filled injection pens with fixed dosing. Compounded versions are prepared by licensed compounding pharmacies to a provider's prescription, allowing for customized dosing and formulation.

The active ingredient is the same — semaglutide is semaglutide, tirzepatide is tirzepatide. The difference is in manufacturing, delivery format, regulatory pathway, and cost. Brand-name versions are typically significantly more expensive, especially without insurance coverage.

Compounded medications have been a standard part of medicine for decades — they exist to fill gaps where mass-manufactured products don't meet individual patient needs. The quality of a compounded medication depends on the pharmacy producing it, which is why provider sourcing matters.

At Balanced, your provider discusses both options during your consultation. Factors include cost, insurance coverage, dosing flexibility, availability, and your preference. We prescribe what makes the most clinical sense for your situation, with full transparency about the source.

Medical Weight Loss →  ·  Medical Weight Loss →

GLP-1 medications for weight management are generally appropriate for adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition (such as type 2 diabetes, hypertension, or high cholesterol). However, these are general guidelines — your provider evaluates your full clinical picture.

At Balanced, qualification isn't just about BMI. We look at your metabolic labs, hormonal status, body composition, health history, and treatment goals. Some patients with a BMI under 30 have significant metabolic dysfunction that would benefit from GLP-1 therapy. Others might be better served by addressing hormonal imbalances or other root causes first.

Contraindications include a personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, active pancreatitis, and pregnancy. Certain medical conditions and medications may require additional evaluation before starting.

If you're unsure whether you qualify, the consultation process at Balanced answers that question definitively. We'd rather evaluate you thoroughly and determine you're not a candidate than prescribe something that isn't right for your biology.

Medical Weight Loss →  ·  Services →

Yes — GLP-1 medications are not exclusively for patients with large amounts of weight to lose. The clinical question isn't how much weight you need to lose, but whether metabolic dysfunction is contributing to your difficulty losing it.

A patient who needs to lose 20 pounds but has been unable to despite consistent effort may have underlying insulin resistance, hormonal imbalance, or metabolic signaling issues that a GLP-1 can help correct. In these cases, the medication addresses the biology that's blocking progress — not just suppressing appetite.

That said, not every patient who wants to lose 20 pounds needs a GLP-1. If your metabolic labs are healthy and you haven't actually committed to consistent nutrition and exercise, the solution might be behavioral rather than pharmaceutical. At Balanced, we assess that honestly during consultation.

For patients with modest weight loss goals, the treatment duration is typically shorter, the dose may stay lower, and the transition off medication happens sooner. The same principles apply — peptide support for muscle preservation, lab monitoring, and a planned exit strategy.

Medical Weight Loss →  ·  Services →

GLP-1 medications and bariatric surgery represent different levels of intervention on the same spectrum. Bariatric surgery physically alters the digestive system — reducing stomach size and/or rerouting intestinal pathways — to produce dramatic, permanent changes in food capacity and nutrient absorption. GLP-1 medications modify hormonal signaling to reduce appetite and improve metabolic function without altering anatomy.

Bariatric surgery typically produces larger total weight loss and may be more appropriate for patients with severe obesity or life-threatening metabolic conditions. It also carries surgical risks, requires permanent dietary changes, and necessitates lifelong nutritional supplementation.

GLP-1 therapy is less invasive, reversible, and can be a first-line option for patients who want medical intervention without surgery. The trade-off is that the effects are dependent on continued medication use (or a very successful transition plan), whereas surgical changes are permanent.

At Balanced, some patients come to us specifically because they want to avoid surgery. Others have already had bariatric surgery and are using GLP-1 therapy to manage plateau or regain. Both paths are valid — the right choice depends on your clinical situation, risk tolerance, and long-term goals.

Medical Weight Loss →  ·  Medical Weight Loss →

Dieting addresses behavior — what you eat and how much. Medical weight loss addresses biology — why your body is holding onto weight despite your efforts, and what metabolic, hormonal, or signaling dysfunction is preventing progress.

Many patients who come to Balanced have been dieting successfully for years — in the sense that they eat well and exercise consistently — but can't break through a plateau or can't lose the last 20–30 pounds. That's not a willpower failure. It's often a biological one: insulin resistance, cortisol elevation, thyroid underperformance, declining growth hormone, or disrupted appetite signaling.

Medical weight loss uses tools that address these biological barriers directly: GLP-1 medications to reset appetite signaling, metabolic labs to identify root causes, hormone optimization to correct imbalances, and peptide therapy to preserve lean mass and energy during the process.

The other critical difference is sustainability. Diets work until they don't — typically when willpower runs out or life gets stressful. Medical weight loss changes the biological environment so maintaining results requires less constant effort. The goal isn't to white-knuckle your way to a number. It's to shift your metabolic baseline.

Medical Weight Loss →  ·  Medical Weight Loss →

If you're genuinely consistent with nutrition and exercise but the scale won't budge, there's almost certainly a biological factor at play. The most common culprits we see at Balanced are insulin resistance, cortisol elevation, thyroid underperformance, declining sex hormones, and disrupted metabolic signaling.

Insulin resistance is particularly common and often undiagnosed. Your fasting glucose might look normal on a basic panel, but advanced markers like fasting insulin, HOMA-IR, and A1c can reveal metabolic dysfunction that standard bloodwork misses. When your cells resist insulin's signal, your body preferentially stores fat — especially around the abdomen — regardless of caloric intake.

Cortisol — the stress hormone — directly promotes visceral fat storage. If you're chronically stressed, under-sleeping, or overtraining, cortisol can override even a perfect diet. Thyroid issues, particularly subclinical hypothyroidism, slow your metabolic rate without producing obvious symptoms beyond weight gain and fatigue.

This is exactly why Balanced starts every weight loss program with comprehensive labs — not a generic prescription. The answer to "why can't I lose weight" is in your blood work. Once we identify the driver, we can target it with the right intervention — which might be a GLP-1, might be hormone therapy, might be both.

Medical Weight Loss →  ·  Services →

At Balanced, your weight loss program begins with a comprehensive metabolic panel that goes well beyond standard bloodwork. We test hormone levels (thyroid panel, testosterone, estrogen, DHEA-S, cortisol), metabolic markers (fasting insulin, HOMA-IR, A1c, fasting glucose, lipid panel), inflammatory markers (CRP, homocysteine), liver and kidney function, vitamin levels (B12, D, iron/ferritin), and additional biomarkers that reveal what's actually driving your weight gain.

This depth matters because two patients with the same BMI can have completely different metabolic profiles — and need completely different treatment approaches. One might need a GLP-1 to address insulin resistance. Another might need thyroid optimization first. A third might benefit most from addressing cortisol before adding any medication.

The 60+ biomarker panel also establishes a baseline for tracking progress. When we re-test labs during your program, we're measuring objective metabolic improvement — not just weight lost. A patient whose insulin sensitivity improves, inflammatory markers drop, and hormone levels normalize has achieved something far more valuable than a number on a scale.

Labs are typically drawn at your first visit or shortly after your consultation. Results take a few days, and your provider reviews them in detail before prescribing anything.

Services →  ·  Medical Weight Loss →

Your consultation starts with a comprehensive health intake — your weight history, previous weight loss attempts, current medications, lifestyle factors, dietary patterns, exercise habits, and what you've tried before. This conversation gives your provider the context to build a personalized program rather than applying a template.

Next, we order comprehensive lab work (60+ biomarkers) to identify the metabolic, hormonal, and inflammatory factors driving your weight. Labs are typically drawn the same day. We also take baseline body composition measurements.

Once your labs return (usually within a few days), your provider reviews every marker with you — not just the flagged values, but how each one relates to your weight and overall health. From there, we build your treatment plan: which medication (semaglutide, tirzepatide, or alternative), supporting peptide therapy, dosing schedule, nutritional guidance, and a monitoring timeline.

You leave with a clear understanding of what's driving the weight, what the plan is to address it, what to expect in terms of timeline and side effects, and when your next check-in is. This isn't a five-minute telehealth prescription. It's a clinical assessment that becomes the foundation for your entire program.

Medical Weight Loss →  ·  Contact →

Slim & Strong is one of Balanced's structured wellness packages designed for patients pursuing weight loss with muscle preservation. It bundles the core components of our medical weight loss approach — GLP-1 medication, supportive therapies, and monitoring — into a cohesive program at preferred pricing.

The philosophy behind Slim & Strong is in the name: the goal isn't just to get slim. It's to get slim and strong — losing fat while preserving the lean muscle that keeps your metabolism healthy, your energy up, and your results sustainable after the active weight loss phase.

Specific package details — what's included, pricing, and duration — are discussed during your consultation because we want to make sure the package matches your needs before you commit. Not every weight loss patient needs the same level of support, and we'd rather customize than over-prescribe.

If you're interested in Slim & Strong, the first step is a consultation where we evaluate your labs, body composition, and goals. From there, your provider recommends whether this package or a different approach is the right fit.

Slim And Strong →  ·  Medical Weight Loss →

Semaglutide dosing starts low and increases gradually over several weeks to minimize side effects — particularly nausea. This process is called dose titration or escalation, and it's essential for tolerability.

The typical escalation follows a step-up pattern: starting at the lowest dose for 4 weeks, then increasing to the next level for another 4 weeks, and continuing upward until reaching the therapeutic target dose. The total escalation period is usually 16–20 weeks to reach the full dose.

Not every patient follows the same timeline. If you're tolerating the current dose well, escalation proceeds on schedule. If GI side effects are significant at a particular level, your provider may hold at that dose for an additional 2–4 weeks before increasing. There's no penalty for taking more time — the goal is reaching an effective dose with manageable side effects.

Some patients achieve their goals at a mid-range dose and never need to escalate to the maximum. Others benefit from the full dose. Your provider monitors your response — weight trajectory, side effects, and lab markers — to determine the right dose for you, not just the highest available dose.

Medical Weight Loss →  ·  Medical Weight Loss →

Both semaglutide and tirzepatide are administered once weekly via subcutaneous injection. You choose the same day each week and inject at any time of day — though many patients prefer a consistent time to build the habit.

The injection is subcutaneous (just under the skin), typically in the abdomen, thigh, or upper arm. The needle is thin gauge — similar to an insulin needle — and the injection takes seconds. Most patients find it manageable after the first one or two.

If you're using brand-name versions (Ozempic, Wegovy, Mounjaro, Zepbound), they come in pre-filled auto-injector pens. Compounded versions may require drawing from a vial with a syringe — your provider or nurse teaches you the technique during your first visit.

Consistency matters more than precision. If you miss your usual day by a day or two, take the injection as soon as you remember and resume your regular schedule. If you miss by more than a few days, contact your provider for guidance rather than doubling up.

Medical Weight Loss →  ·  Contact →

Yes — GLP-1 medications were originally developed for type 2 diabetes management. Semaglutide (Ozempic) and tirzepatide (Mounjaro) both have FDA approvals specifically for type 2 diabetes, in addition to their weight management indications (Wegovy and Zepbound, respectively).

For patients with both type 2 diabetes and weight management goals, GLP-1 therapy can address both simultaneously — improving blood sugar control while facilitating weight loss. This dual benefit is one of the reasons these medications have become so widely prescribed.

However, if you're already on diabetes medications, your provider needs to coordinate carefully. GLP-1 medications affect blood sugar, and combining them with other diabetes drugs (particularly sulfonylureas or insulin) can increase hypoglycemia risk. Your medication regimen may need adjustment.

At Balanced, your provider reviews your complete medication list and diabetes management history during the consultation. We coordinate with your endocrinologist or PCP if needed. The goal is a cohesive metabolic strategy, not a pile of overlapping prescriptions.

Medical Weight Loss →  ·  Services →

The most important contraindications for GLP-1 medications include a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), active or recent pancreatitis, and pregnancy or planned pregnancy.

GLP-1 medications carry a boxed warning about thyroid C-cell tumors based on rodent studies. While this hasn't been confirmed in human studies, patients with thyroid cancer risk factors are not candidates.

Other conditions requiring careful evaluation: gallbladder disease (GLP-1 medications may increase gallstone risk), severe GI conditions, history of pancreatitis, severe kidney disease, and diabetic retinopathy. Certain medication combinations also need assessment — particularly insulin and sulfonylureas.

At Balanced, every contraindication is screened during the consultation and lab review process. If a GLP-1 is not appropriate for you, your provider discusses alternative approaches — which might include peptide therapy for body composition, hormone optimization, or metabolic support through other pathways. A contraindication for GLP-1 therapy doesn't mean there's no medical weight loss option for you.

Medical Weight Loss →  ·  Services →

No. GLP-1 medications are contraindicated during pregnancy and breastfeeding. There is insufficient safety data for use during pregnancy, and the appetite-suppressing and metabolic effects could impact fetal development and nutritional adequacy.

If you become pregnant while on a GLP-1 medication, discontinue use and contact your provider immediately. It's recommended to stop GLP-1 therapy at least 2 months before a planned pregnancy — semaglutide's longer half-life means it takes time to fully clear your system.

For breastfeeding, the concern is both direct transfer through breast milk (which hasn't been adequately studied) and the impact on maternal nutrition and milk supply from appetite suppression.

If you're planning pregnancy in the near future but want to optimize your metabolic health beforehand, your provider at Balanced can discuss alternative approaches that are safe during the preconception period. There are non-GLP-1 options for metabolic support that may be appropriate.

Medical Weight Loss →  ·  Hormone Therapy →

Some patients report hair thinning or shedding during GLP-1 therapy. This is likely related to the rapid weight loss itself rather than a direct drug effect — a phenomenon called telogen effluvium, where the stress of significant caloric restriction and rapid body composition change pushes hair follicles into a resting phase prematurely.

Telogen effluvium is temporary and reversible once the body stabilizes at its new weight and nutritional intake normalizes. Hair typically begins regrowing within a few months of reaching a stable weight.

The risk is higher when weight loss is very rapid and when nutritional deficiencies develop — which is more likely when appetite suppression is severe and protein, iron, biotin, and zinc intake drops significantly. This is another reason adequate protein intake is critical during GLP-1 therapy.

At Balanced, we monitor for nutritional deficiencies through lab work and emphasize protein intake from day one. For patients concerned about hair, peptides like GHK-Cu can be added to support hair follicle health during the weight loss phase. Addressing the cause (nutritional support) is more effective than treating the symptom after it appears.

Medical Weight Loss →  ·  Peptide Therapy →

Protein intake during GLP-1 therapy is critical — and most patients undereat protein because appetite suppression makes it hard to consume enough food overall. We typically recommend 0.7–1 gram of protein per pound of lean body mass per day, which is higher than general dietary guidelines but essential for preserving muscle during calorie-restricted weight loss.

When your appetite is suppressed and you're eating significantly less, what you do eat needs to be optimized. Protein should be the priority at every meal. If you're only eating 1,000–1,200 calories a day (which is common on GLP-1 therapy), and 40–50% of those calories aren't from protein, you're underfueling the muscle tissue that keeps your metabolism healthy.

Practical strategies: prioritize protein at every meal before adding carbs or fats. Use protein supplements (shakes, bars) to fill gaps on days when appetite is especially low. Track protein intake for at least the first few weeks until you develop an intuitive sense of how much you're getting.

At Balanced, nutritional guidance is built into your program. We discuss protein targets, meal strategies, and how to eat effectively when you don't feel hungry — because that's the paradox of GLP-1 therapy: the medication makes you less hungry, but you still need to eat strategically.

Medical Weight Loss →  ·  Medical Weight Loss →

Your dietary approach during GLP-1 therapy should prioritize protein first, followed by vegetables and fiber, with moderate healthy fats and limited processed carbohydrates. The medication suppresses your appetite, so every calorie you do eat needs to count.

Protein at every meal is non-negotiable — aim for 0.7–1g per pound of lean body mass daily. Fiber-rich vegetables support gut health and digestion, which matters because GLP-1 medications slow gastric emptying. Healthy fats (olive oil, avocado, nuts) provide essential nutrients but should be moderated since they can exacerbate nausea, especially during dose escalation.

Foods to minimize: high-fat and greasy foods (worst for nausea), refined sugars, processed foods, excessive alcohol, and carbonated beverages. Eating slowly and stopping at the first sign of fullness prevents the uncomfortable "overfull" sensation that GLP-1 patients often describe.

Hydration is critical — many patients on GLP-1 therapy under-hydrate because reduced food intake also reduces water intake from food. Aim for at least 64 ounces of water daily, more if you're active.

At Balanced, your provider discusses nutrition as part of the program — not as a generic handout but as a specific plan tailored to your caloric needs, protein targets, and food preferences.

Medical Weight Loss →  ·  Medical Weight Loss →

Yes — and you should. Exercise, particularly resistance training, is one of the most important factors in preserving lean muscle during GLP-1-assisted weight loss. The medication handles the caloric side; exercise protects the muscle side.

Resistance training 2–4 times per week is recommended. This doesn't need to be extreme — moderate intensity with progressive overload is sufficient. The goal is to give your body a reason to maintain muscle tissue even while in a caloric deficit. Walking, cycling, and other cardiovascular activity also support metabolic health and overall wellbeing.

Some patients experience reduced exercise capacity during the first weeks of GLP-1 therapy, particularly during dose escalation when nausea and reduced caloric intake can affect energy levels. This is temporary and typically improves as your body adjusts. Don't push through intense workouts if you're feeling significantly nauseous — moderate activity is better than none.

At Balanced, your program accounts for your current fitness level and goals. The peptide therapy component also supports exercise recovery by maintaining growth hormone levels that facilitate muscle repair and adaptation.

Medical Weight Loss →  ·  Strength →

You can, but moderation is important and you should be aware of how GLP-1 medications change the equation. First, GLP-1 medications affect blood sugar regulation, and alcohol also affects blood sugar — combining them can increase hypoglycemia risk, particularly on an empty stomach.

Second, alcohol is calorically dense and nutritionally empty. When you're eating significantly less due to appetite suppression, every calorie matters. Replacing protein-rich food with alcohol undermines the nutritional strategy that makes GLP-1 therapy effective.

Third, many patients on GLP-1 therapy report that their alcohol tolerance decreases — they feel the effects of alcohol more quickly and more intensely. This is likely related to the slower gastric emptying caused by the medication and the lower food volume in the stomach.

Our general guidance: if you choose to drink, do so moderately and never on an empty stomach. Prioritize your protein and nutrition first. Be aware that your response to alcohol may change. And if weight loss is your primary goal, reducing or eliminating alcohol during the active treatment phase produces faster results.

Medical Weight Loss →  ·  Services →

Treatment duration depends on your goals, your metabolic response, and your transition plan. Most patients at Balanced are on active GLP-1 therapy for 6–18 months, though some choose to stay on a maintenance dose longer.

The general framework: the active weight loss phase lasts until you've reached your body composition goal or a stable plateau. This is followed by a gradual taper phase where the dose is reduced incrementally while monitoring for weight stability. Some patients transition completely off the medication; others maintain a low dose long-term.

The right answer depends on your biology and your risk factors. Patients with significant insulin resistance or metabolic syndrome may benefit from longer treatment duration. Patients with modest goals and healthy metabolic markers after weight loss may transition off sooner.

At Balanced, the exit strategy is built into your program from day one. We're not just prescribing indefinitely — we're working toward a point where your metabolic health, habits, and body composition can be maintained with progressively less pharmaceutical support. But we're also honest: some patients do better with ongoing low-dose maintenance, and there's no shame in that approach.

Medical Weight Loss →  ·  Medical Weight Loss →

"Semaglutide face" or "Ozempic face" refers to facial volume loss and a gaunt, aged appearance that can occur with rapid, significant weight loss — on GLP-1 medications or any other method. When you lose a large amount of body fat quickly, fat pads in the face deflate, skin loses structural support, and the result can be a hollowed, tired look.

This isn't a side effect unique to semaglutide — it's a consequence of rapid weight loss, particularly when muscle mass is lost alongside fat. The face is one of the most visible areas where volume loss shows.

Prevention starts with the approach we've been discussing: adequate protein intake, resistance training, and peptide therapy for muscle preservation slow the rate at which facial fat pads deflate. Gradual weight loss (rather than maximum-speed loss) also reduces facial aging effects.

For patients who've already experienced facial volume loss during weight loss, aesthetic treatments can restore what was lost. Dermal fillers, PRFM therapy, and RF microneedling can rebuild facial volume, structure, and skin quality. This is one of the advantages of Balanced's integrated model — we address the metabolic, compositional, and aesthetic aspects of your transformation under one roof.

Medical Weight Loss →  ·  Dermal Fillers →

Yes — and many patients find it the natural next step. GLP-1-assisted weight loss reduces total body fat, but it can't control where fat comes from or address loose skin that remains after significant weight reduction. Body contouring and skin tightening treatments address the shape and texture changes that the scale doesn't reflect.

At Balanced, post-weight-loss options include RF microneedling (Secret Pro) for skin tightening, body contouring treatments for stubborn residual fat deposits, and dermal fillers for facial volume restoration if needed. The timing matters — we typically recommend stabilizing at your target weight for 2–3 months before starting contouring treatments.

This is where Balanced's full-spectrum model creates a unique advantage. Patients at a GLP-1-only clinic have to find a separate provider for the aesthetic work. Here, your medical weight loss provider and your aesthetic provider are under the same roof, which means your post-loss treatment plan is coordinated from the start.

Medical Weight Loss →  ·  Skin Rejuvenation →

Hormones regulate virtually every aspect of metabolism — from how your body stores fat to how efficiently it burns calories to how hungry you feel throughout the day. When hormonal balance shifts, weight gain often follows even without changes in diet or exercise.

Insulin resistance is the most direct hormonal driver of weight gain. When your cells stop responding to insulin efficiently, your body produces more insulin, which promotes fat storage — particularly visceral fat around the abdomen. This can create a vicious cycle: more fat increases inflammation, which worsens insulin resistance.

Cortisol (the stress hormone) signals your body to store fuel for emergencies. Chronic stress, poor sleep, and overtraining keep cortisol elevated, directly promoting fat accumulation. Thyroid hormones regulate your basal metabolic rate — even mild underperformance can slow metabolism enough to cause gradual weight gain. Declining testosterone (in both men and women) reduces lean muscle mass, which lowers metabolic rate.

At Balanced, comprehensive lab work evaluates all of these hormonal axes before prescribing a weight loss program. Addressing only appetite (with a GLP-1) while ignoring insulin resistance, cortisol, or thyroid dysfunction produces incomplete results.

Medical Weight Loss →  ·  Services →

Insulin resistance is one of the most common and underdiagnosed drivers of stubborn weight gain. When your cells become resistant to insulin's signal, your pancreas produces more insulin to compensate. Elevated insulin levels directly promote fat storage and inhibit fat breakdown — meaning your body preferentially stores calories as fat even at a normal caloric intake.

The hallmark of insulin resistance-driven weight gain is abdominal fat accumulation that doesn't respond proportionally to diet and exercise. You might lose weight from other areas but the midsection stays. That's because visceral fat has a high density of insulin receptors and responds directly to insulin signaling.

Standard blood work often misses insulin resistance. A normal fasting glucose doesn't rule it out. At Balanced, we measure fasting insulin levels, HOMA-IR (a calculated insulin resistance index), and A1c in addition to standard glucose — because insulin resistance develops years before blood sugar becomes abnormal.

GLP-1 medications, particularly tirzepatide (which includes a GIP pathway), directly improve insulin sensitivity as part of their mechanism. But for some patients, addressing insulin resistance through metabolic optimization — nutrition, exercise, hormone balance — may be sufficient without a GLP-1. The labs determine the approach.

Medical Weight Loss →  ·  Services →

GLP-1 medications are backed by extensive clinical research — they are among the most studied weight management interventions in pharmaceutical history. They are not a fad, a celebrity gimmick, or a shortcut. They are prescription medications that modify metabolic signaling to produce clinically meaningful changes in body weight and metabolic health.

That said, how they're used matters as much as the medication itself. A GLP-1 prescribed through a quick telehealth visit without lab work, without monitoring, and without a support program will produce different outcomes than the same medication used within a comprehensive metabolic protocol. The medication is a tool — the program around it determines the results.

The social media attention has created both awareness and misinformation. The awareness is good — it's brought medical weight loss into mainstream conversation. The misinformation is that GLP-1 therapy is simple, one-size-fits-all, and consequence-free. It requires clinical oversight, nutritional strategy, and a plan for long-term maintenance.

At Balanced, we welcome the increased interest because it brings patients to evidence-based care rather than fad diets. But we're clear from the start: this is a medical program, not a trend you try for three months.

Medical Weight Loss →  ·  Medical Weight Loss →

At Balanced, yes — we offer telehealth consultations for medical weight loss patients who don't live in the Atlanta metro area. The program structure is the same: comprehensive lab work (ordered to a lab near you), provider consultation via video, prescription management, and ongoing monitoring through scheduled telehealth visits.

However, we don't operate like the large telehealth companies that prescribe GLP-1 medications with minimal oversight. Our program still includes comprehensive lab work before prescribing, regular follow-up appointments, peptide therapy for muscle preservation, and a planned transition strategy. The medium is virtual; the clinical depth is the same.

Telehealth availability depends on state licensing requirements, so coverage area varies. If you're interested in working with Balanced remotely, the first step is reaching out to confirm we can serve your state.

Many of our telehealth patients are people who tried a telehealth-only GLP-1 service, felt abandoned after the first prescription, and want a provider who actually monitors their program. If that's your experience, you're not alone — and the transition to our platform is straightforward.

Telehealth →  ·  Medical Weight Loss →

Phentermine is an older weight loss medication that works as a sympathomimetic amine — essentially a stimulant that suppresses appetite by affecting norepinephrine in the brain. GLP-1 medications work through a completely different mechanism: they mimic a gut hormone that regulates appetite, blood sugar, and gastric emptying.

The differences are significant. Phentermine has a stimulant side-effect profile: increased heart rate, elevated blood pressure, insomnia, anxiety, and dry mouth. It's typically prescribed for short-term use only (12 weeks). GLP-1 medications don't carry stimulant risks and can be used for longer treatment periods.

Phentermine also doesn't address underlying metabolic issues. It temporarily suppresses appetite through a central nervous system mechanism, but once you stop, appetite returns to baseline with no metabolic improvement. GLP-1 medications improve insulin sensitivity and metabolic signaling — effects that can persist to some degree beyond the active treatment period.

GLP-1 medications have largely replaced phentermine as the standard of care in medical weight management because of their superior metabolic effects, better safety profile for long-term use, and more sustainable outcomes.

Medical Weight Loss →  ·  Medical Weight Loss →

The differences come down to depth, support, and outcomes. Most telehealth GLP-1 companies operate on a high-volume model: brief consultation, prescription, auto-ship. There's typically no comprehensive lab work, no metabolic evaluation, no peptide support for muscle preservation, minimal monitoring, and no transition plan.

At Balanced, the program includes comprehensive metabolic labs (60+ biomarkers), provider review of every marker, personalized medication selection based on your biology, supportive peptide therapy to preserve lean mass, regular check-ins and follow-up labs, nutritional guidance, and a planned taper/transition strategy.

The result is fundamentally different. Patients who've experienced both describe the difference between getting a prescription and getting a program. One patient put it well: she'd done Ozempic through a telehealth company and felt abandoned after month two. She didn't want a prescription — she wanted a program.

The cost is higher than a telehealth-only prescription. But the investment produces different results: better body composition (not just weight loss), preserved muscle, fewer side effects through proper management, and sustainable outcomes with a lower regain rate.

Medical Weight Loss →  ·  Medical Weight Loss →

GLP-1 medications reduce total body fat, including visceral fat (the deep abdominal fat around organs). Tirzepatide may offer additional benefit for visceral fat through its GIP pathway, which plays a role in fat distribution and insulin sensitivity. Clinical data has shown significant reductions in waist circumference alongside total weight loss.

However, GLP-1 medications don't selectively target belly fat. Total body fat reduction happens systemically — meaning fat comes off from everywhere, with genetics influencing which areas respond first. Some patients see early abdominal reduction; others lose from extremities first.

For patients whose primary concern is stubborn belly fat specifically — particularly those who are otherwise lean and fit — Tesamorelin (a growth hormone peptide) may be more targeted. It specifically addresses visceral fat through growth hormone signaling. At Balanced, we sometimes combine a GLP-1 with Tesamorelin for patients with significant visceral fat who also need overall weight management.

The bottom line: GLP-1 therapy will reduce belly fat as part of overall fat loss. For targeted visceral fat reduction in already-lean patients, peptide-based approaches may be more appropriate. Your labs and body composition assessment guide the decision.

Medical Weight Loss →  ·  Peptide Therapy →

"Food noise" is the term patients use to describe the constant mental chatter about food — thinking about what to eat next, craving specific foods, negotiating with yourself about portions, and the mental exhaustion of perpetual dietary willpower. For many patients, it's not hunger in the physical sense — it's a neurological loop that dominates mental energy.

GLP-1 medications quiet this noise by modifying the brain's appetite and reward signaling. GLP-1 receptors exist not just in the gut but in the brain's hypothalamus and reward centers. When these medications activate those receptors, the urgency and preoccupation around food diminishes. Patients describe it as the first time food didn't dominate their thoughts.

This effect is often the most emotionally impactful change patients experience — even more than the weight loss itself. When the mental burden of food decisions lifts, patients redirect that cognitive energy toward work, relationships, exercise, and quality of life.

The food noise reduction is one of the reasons GLP-1 therapy often produces results where traditional dieting failed. It's not about willpower — it's about quieting a neurological signal that was overpowering conscious decision-making.

Medical Weight Loss →  ·  Medical Weight Loss →

Absolutely. GLP-1 medications are prescribed equally for men and women. The misconception that these are primarily women's medications comes from marketing and social media trends — not clinical reality.

Men often present with a different metabolic profile than women: higher rates of insulin resistance, visceral fat accumulation, and metabolic syndrome. GLP-1 medications — particularly tirzepatide with its GIP pathway — can be especially effective for the insulin-resistant, belly-fat-dominant pattern common in men over 40.

At Balanced, our medical weight loss program for men often combines a GLP-1 with growth hormone peptides and, when indicated, testosterone optimization. This combination addresses body composition from multiple angles: the GLP-1 handles appetite and metabolic signaling, the peptide protects muscle, and testosterone (if low) supports lean mass, energy, and metabolic rate.

We also see men who are fitness-conscious but frustrated by stubborn abdominal fat despite strong diet and exercise habits. For this profile, a GLP-1 combined with Tesamorelin can be remarkably effective.

Medical Weight Loss →  ·  TRT →

"GLP-1 face" is the same phenomenon as "Ozempic face" or "semaglutide face" — facial volume loss and a gaunt appearance caused by rapid weight loss, not by the medication itself. When significant fat is lost quickly, facial fat pads deflate, skin loses underlying structural support, and the face can look hollow or aged.

Prevention strategies during active weight loss: adequate protein intake (to minimize overall tissue loss), resistance training, gradual rather than maximally aggressive weight loss, and peptide support for lean mass preservation. These don't eliminate facial volume loss entirely during significant weight loss, but they reduce its severity.

If facial changes do occur, they're treatable. At Balanced, patients have access to aesthetic restoration alongside their weight loss program — dermal fillers for volume replacement, PRFM therapy for under-eye hollowing, RF microneedling for skin quality and tightness, and facial balancing to restore natural contours.

This integrated approach is a significant advantage over standalone weight loss clinics. You don't need to find a separate provider for the aesthetic concerns — it's all coordinated under one roof as part of your complete transformation.

Medical Weight Loss →  ·  Dermal Fillers →

In many cases, yes — GLP-1 medications can be used after bariatric surgery, particularly for patients experiencing weight regain or plateau. However, this requires careful clinical evaluation because bariatric surgery alters your GI anatomy and may affect how the medication is absorbed and tolerated.

Patients who've had sleeve gastrectomy or gastric bypass have a smaller stomach volume and altered gut hormone profiles. GLP-1 medications further slow gastric emptying and reduce appetite, so the combined effect on eating capacity needs to be managed carefully to avoid severe nausea, nutritional deficiency, or dehydration.

Dose titration may need to be more conservative, and nutritional monitoring is especially critical. Bariatric patients are already at higher risk for protein deficiency and micronutrient gaps — adding GLP-1 appetite suppression on top requires proactive nutritional management.

At Balanced, we evaluate post-bariatric patients individually. Your surgical history, current nutritional status, and specific goals all factor into whether and how a GLP-1 medication fits your plan.

Medical Weight Loss →  ·  Services →

GLP-1 medications carry a boxed warning about thyroid C-cell tumors based on findings in rodent studies where the medications caused medullary thyroid carcinoma at very high doses. This finding has not been confirmed in human studies, but out of caution, patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome should not use GLP-1 medications.

For patients without these risk factors, GLP-1 therapy has not been shown to impair normal thyroid function. However, thyroid health is important for weight management regardless — subclinical hypothyroidism is one of the most common and underdiagnosed contributors to weight gain.

At Balanced, your pre-treatment lab panel includes a comprehensive thyroid panel (TSH, free T3, free T4, and sometimes thyroid antibodies). If thyroid dysfunction is present, addressing it may be necessary before or alongside GLP-1 therapy for optimal results. Suppressing appetite doesn't help if your metabolic rate is depressed by an underperforming thyroid.

Medical Weight Loss →  ·  Services →

Yes — GLP-1 medications address multiple components of metabolic syndrome simultaneously, which is one of their most significant clinical advantages. Metabolic syndrome is a cluster of conditions — elevated blood sugar, excess abdominal fat, abnormal cholesterol, and high blood pressure — that together dramatically increase cardiovascular and diabetes risk.

GLP-1 therapy improves insulin sensitivity, reduces visceral fat, lowers blood sugar and A1c levels, and has demonstrated cardiovascular benefits in clinical trials. Tirzepatide's dual GIP/GLP-1 mechanism may offer additional metabolic benefits beyond GLP-1 alone.

For patients with metabolic syndrome, the weight loss from GLP-1 therapy is almost secondary to the metabolic improvements. A patient who loses 15% of body weight while normalizing insulin sensitivity, reducing inflammatory markers, and improving lipid profiles has achieved something far more valuable than the weight loss alone.

At Balanced, metabolic syndrome patients receive particular attention during lab review. We track not just weight but the full constellation of metabolic markers — because reversing metabolic syndrome is a medical outcome, not just a cosmetic one.

Medical Weight Loss →  ·  Services →

Ozempic and Wegovy are both semaglutide manufactured by Novo Nordisk, but they're approved for different indications and come in different dose ranges. Ozempic is approved for type 2 diabetes management. Wegovy is approved specifically for chronic weight management.

The active molecule is identical. The difference is in the dosing — Wegovy reaches a higher maximum dose (2.4mg) than Ozempic (2.0mg for diabetes), and the escalation schedule differs slightly. Wegovy was studied specifically for weight loss in clinical trials (the STEP trials), which is why it carries the weight management indication.

In practice, many providers prescribe Ozempic off-label for weight management when Wegovy is unavailable or prohibitively expensive. The clinical effect is similar, though the maximum dose is slightly lower.

At Balanced, your provider prescribes based on your clinical needs, availability, and cost considerations. Whether you receive brand-name or compounded semaglutide, the active ingredient and clinical monitoring are the same.

Medical Weight Loss →  ·  Medical Weight Loss →

Mounjaro and Zepbound are both tirzepatide manufactured by Eli Lilly. Like the Ozempic/Wegovy distinction, they're the same molecule approved for different uses. Mounjaro is approved for type 2 diabetes. Zepbound is approved specifically for chronic weight management.

The active ingredient and mechanism are identical — both activate GIP and GLP-1 receptors. The difference is regulatory indication, dosing ranges studied in clinical trials, and how they're prescribed and covered by insurance.

In practice, availability and cost often drive which formulation patients receive. Zepbound may be available when Mounjaro isn't, or vice versa. Compounded tirzepatide is another option that some providers prescribe.

At Balanced, the brand name matters less than the clinical protocol. Whether you receive Mounjaro, Zepbound, or compounded tirzepatide, the medication, monitoring, and support program are the same. Your provider discusses all available options and helps you choose based on clinical appropriateness and cost.

Medical Weight Loss →  ·  Medical Weight Loss →

The fundamental difference is mechanism and metabolic impact. Older weight loss medications — phentermine, orlistat, sibutramine — primarily worked through appetite suppression (stimulant effect), fat absorption blocking, or central nervous system manipulation. They didn't address underlying metabolic dysfunction.

GLP-1 and GIP/GLP-1 medications work through hormonal pathways that regulate appetite, blood sugar, insulin sensitivity, and metabolic signaling. They don't just make you eat less — they improve how your body processes and stores energy. This produces more comprehensive metabolic improvement alongside weight loss.

The safety profiles are also dramatically different. Older medications carried significant cardiovascular risks (sibutramine was pulled from market), liver damage risk (orlistat), or abuse potential (phentermine). GLP-1 medications have actually demonstrated cardiovascular protective effects in clinical trials.

The other major difference is sustainability. Older drugs provided temporary appetite suppression with minimal lasting metabolic change. GLP-1 therapy, when used as part of a comprehensive program with metabolic optimization, can produce changes in insulin sensitivity and metabolic health that persist beyond the active treatment period.

Medical Weight Loss →  ·  Medical Weight Loss →

Rapid weight loss from any method — including GLP-1 therapy — increases the risk of gallstone formation. This isn't unique to GLP-1 medications; it's a well-known consequence of losing weight quickly. When the body mobilizes fat stores rapidly, cholesterol concentration in bile increases, which can lead to gallstone development.

Clinical trials with GLP-1 medications have reported gallbladder-related events (gallstones, cholecystitis) at slightly higher rates than placebo. Patients with pre-existing gallbladder conditions or a history of gallstones should discuss this risk with their provider before starting.

Symptoms to watch for include upper-right abdominal pain, particularly after eating fatty meals, nausea, and pain radiating to the back or shoulder. If you experience these symptoms while on GLP-1 therapy, contact your provider promptly.

At Balanced, gallbladder risk is assessed during your initial consultation. We monitor for symptoms throughout treatment and adjust the weight loss pace if needed. Gradual weight loss (which our comprehensive program promotes) carries lower gallbladder risk than very rapid loss.

Medical Weight Loss →  ·  Services →

Five-amino-1MQ (5-amino-1MQ) is a small molecule that works at the mitochondrial level to support metabolic function and fat metabolism. It was originally studied in the context of obesity and targets nicotinamide N-methyltransferase (NNMT), an enzyme that plays a role in energy metabolism and fat cell regulation.

By inhibiting NNMT, 5-amino-1MQ helps improve cellular energy metabolism and insulin sensitivity. Unlike GLP-1 medications that primarily work through appetite suppression, 5-amino-1MQ addresses metabolic efficiency at the cellular level — helping your body convert fuel to energy more effectively.

One of its advantages is that it's available in oral form and is highly cost-effective — under $200 for a six-week supply. Patients at Balanced who've used it report improvements in both energy levels and body composition, particularly when combined with other metabolic interventions.

At Balanced, 5-amino-1MQ is sometimes used alongside GLP-1 therapy or as part of a metabolic optimization protocol for patients who want cellular-level energy support. It can be combined with lipo-B injections (vitamin B complex) to accelerate the timeline of energy and fat metabolism results.

Peptide Therapy →  ·  Medical Weight Loss →

Tesamorelin and GLP-1 medications attack body fat through complementary mechanisms. The GLP-1 reduces appetite and improves metabolic signaling systemically. Tesamorelin specifically targets visceral fat — the deep abdominal fat around organs — by restoring growth hormone signaling that mobilizes and metabolizes stored visceral fat.

The combination is particularly powerful for patients with the stubborn midsection pattern: significant abdominal fat that doesn't respond proportionally to total body weight loss. GLP-1 therapy reduces overall body fat, and Tesamorelin provides additional targeted reduction of visceral stores.

Tesamorelin also helps preserve lean muscle mass through its growth hormone mechanism — directly supporting the same goal as CJC-1295/Ipamorelin in our standard GLP-1 + peptide protocol. For patients who are already fitness-conscious and primarily want visceral fat reduction, Tesamorelin with a GLP-1 can be more targeted than the standard growth hormone peptide stack.

At Balanced, your provider determines whether standard peptide support or a Tesamorelin-inclusive protocol is more appropriate based on your body composition, visceral fat assessment, and lab work.

Medical Weight Loss →  ·  Peptide Therapy →

GLP-1 medications have demonstrated favorable safety profiles in multi-year clinical trials, and emerging real-world data continues to support their long-term use. Both semaglutide and tirzepatide have been studied for treatment periods exceeding two years, with consistent weight loss maintenance and metabolic improvement.

Long-term safety monitoring includes cardiovascular outcomes (which have actually shown protective effects for semaglutide), pancreatic health, thyroid surveillance, and nutritional status. At Balanced, ongoing lab monitoring ensures we catch any developing concerns early.

The broader safety question isn't just about the medication — it's about the metabolic risks of not treating. Untreated obesity increases risk for type 2 diabetes, cardiovascular disease, joint deterioration, sleep apnea, and multiple cancers. The risk-benefit calculation overwhelmingly favors treatment for appropriate candidates.

The most important long-term safety factor is the quality of the program. A GLP-1 prescription with no monitoring creates more risk than a supervised program that tracks nutritional status, organ function, hormonal health, and body composition throughout treatment. At Balanced, that monitoring is standard.

Medical Weight Loss →  ·  Services →

Loose skin after significant weight loss depends on several factors: how much weight you lose, how quickly you lose it, your age, genetics, skin elasticity, and sun damage history. Generally, losing more than 50 pounds increases the likelihood of noticeable skin laxity, particularly in the abdomen, arms, and thighs.

Slower weight loss gives your skin more time to adapt and contract, which is one of the advantages of our program's comprehensive approach over maximally aggressive weight loss. Maintaining hydration, nutrition, and collagen-supporting therapies during the process also helps.

At Balanced, we address skin concerns proactively during weight loss rather than reactively after. Options include RF microneedling (Secret Pro) for skin tightening, peptides like GHK-Cu for collagen support, red light therapy for skin quality, and body contouring treatments for residual concerns. Timing these treatments appropriately — not too early during active weight loss, not too late after skin has settled into a new position — maximizes results.

For facial skin laxity specifically, we integrate dermal fillers and aesthetic treatments as the face adjusts to its new contours. This is the integrated-care advantage — your weight loss provider and aesthetic provider are the same team.

Medical Weight Loss →  ·  Skin Rejuvenation →

In most cases, yes — but medication interactions must be evaluated individually. GLP-1 medications affect blood sugar regulation and gastric motility, which can interact with certain drug classes.

The most important interactions involve diabetes medications (particularly sulfonylureas and insulin), where combined blood sugar-lowering effects can increase hypoglycemia risk. Your diabetes medication regimen may need adjustment when starting a GLP-1.

GLP-1 medications slow gastric emptying, which can affect the absorption rate of oral medications taken simultaneously. Some oral medications may need timing adjustments to ensure proper absorption. This is particularly relevant for medications with narrow therapeutic windows.

Blood pressure medications may need monitoring because weight loss itself often improves blood pressure, potentially requiring dose reduction of existing antihypertensives.

At Balanced, your provider reviews your complete medication list during the consultation — including supplements — before prescribing. We coordinate with your PCP or specialist when needed. This is another reason comprehensive medical oversight matters: medication management requires clinical judgment, not just a prescription algorithm.

Medical Weight Loss →  ·  Services →

The distinction comes down to clinical depth. A medspa that offers weight loss typically prescribes a GLP-1 medication as an add-on service — limited lab work, minimal monitoring, and no integrated metabolic strategy. A medical weight loss clinic makes weight management the clinical focus, with comprehensive evaluation, evidence-based protocols, and ongoing medical oversight.

Balanced is neither a pure medspa nor a pure weight loss clinic — it's both. The medical weight loss program includes the clinical depth of a dedicated weight management practice (comprehensive labs, metabolic evaluation, peptide support, structured monitoring), combined with the aesthetic capabilities to address body contouring, skin tightening, and facial volume restoration as your body transforms.

This integration matters because weight loss is a whole-body change. Patients who lose significant weight often want to address the aesthetic consequences — loose skin, facial volume changes, body shape refinement. At a standalone weight loss clinic, you'd need to find a separate aesthetic provider. At Balanced, it's coordinated from the start.

The other critical difference is the root-cause approach. We don't just prescribe the medication that suppresses appetite. We identify what's driving the weight gain — hormonal, metabolic, inflammatory — and build a protocol that addresses all of it.

Medical Weight Loss →  ·  About Us →

GLP-1 medications show significant promise for patients with PCOS (polycystic ovary syndrome), which is closely linked to insulin resistance — a primary mechanism that GLP-1 therapy addresses directly.

PCOS-driven weight gain is notoriously resistant to traditional diet and exercise because the underlying insulin resistance promotes fat storage regardless of caloric intake. GLP-1 medications improve insulin sensitivity while reducing appetite and body weight, potentially improving multiple PCOS symptoms simultaneously — not just weight.

Improved insulin sensitivity in PCOS patients can lead to better hormonal balance (reduced androgens), more regular menstrual cycles, and improved fertility outcomes. The weight loss itself also reduces the inflammatory burden that exacerbates PCOS symptoms.

At Balanced, PCOS patients receive a particularly thorough metabolic and hormonal evaluation. The weight loss program may include GLP-1 therapy alongside hormone optimization, anti-inflammatory interventions, and peptide support. If PCOS is your primary concern, your treatment plan addresses the syndrome holistically — not just the weight component.

Medical Weight Loss →  ·  Hormone Therapy →

Lab work tells you definitively — which is why we don't guess. If your hormones, thyroid, insulin sensitivity, cortisol, and inflammatory markers are all optimal and you're gaining weight, the driver is likely behavioral (caloric surplus from eating habits, stress eating, sedentary lifestyle). If any of those markers are off, there's a biological component that behavioral changes alone won't fully correct.

Common indicators that suggest a hormonal or metabolic component: weight gain concentrated in the abdomen despite overall healthy habits, inability to lose weight despite genuine dietary adherence, fatigue disproportionate to your activity level, brain fog, poor sleep quality, and a family history of metabolic conditions.

The honest truth is that for most patients, it's a combination. There may be a hormonal driver making weight loss harder, and there may be behavioral patterns that need adjustment. Medical weight loss addresses the biological side so that behavioral changes can actually produce results.

At Balanced, we don't approach this judgmentally. We test, we show you the numbers, and we build a plan based on what the data reveals. If your labs are optimal and the issue is truly behavioral, we'll tell you that honestly and redirect.

Medical Weight Loss →  ·  Services →

GLP-1 medications are tools, not shortcuts. A shortcut implies bypassing the work. These medications address the biological barriers that make the work ineffective — and they still require the work.

Patients on GLP-1 therapy still need to eat well (with emphasis on protein), exercise consistently (especially resistance training), stay hydrated, manage stress, and build sustainable habits. The medication doesn't do those things for you. What it does is correct the metabolic and neurological signaling that was sabotaging your efforts.

The shortcut narrative is harmful because it discourages people from seeking legitimate medical treatment for a condition with biological drivers. We don't call blood pressure medication a shortcut for managing hypertension. We don't call insulin a shortcut for managing diabetes. GLP-1 therapy for metabolic weight management is medical treatment for a medical condition.

At Balanced, our approach reinforces this framing. The medication resets your metabolic signaling. The program builds the habits and supports the biology so results last after the medication is no longer needed. That's not a shortcut — it's a comprehensive strategy.

Medical Weight Loss →  ·  Medical Weight Loss →

Your first follow-up check-in at Balanced typically happens 4–6 weeks after starting your GLP-1 program. This visit includes a weigh-in and body composition measurement (not just weight — we track fat mass, lean mass, and water), a side-effect assessment, a review of your nutrition and protein intake, and a discussion about dose escalation if applicable.

We compare your current measurements against your baseline to assess early trajectory. It's important to set expectations: 4–6 weeks is early in the process, and the numbers at this stage are directional indicators — not definitive results. Some patients see significant early change; others are still in the dose-building phase.

Your provider also checks in on how you're feeling overall — energy levels, sleep quality, mood, GI symptoms. These qualitative data points matter as much as the quantitative ones early in the program.

Follow-up lab work is typically scheduled at the 3-month mark to assess metabolic improvement alongside weight change. Throughout the program, check-ins happen regularly — this isn't a set-it-and-forget-it prescription.

Medical Weight Loss →  ·  Contact →

Yes — Balanced Aesthetics + Wellness is located in Brookhaven, serving the greater Atlanta metro area including Buckhead, Midtown, Sandy Springs, Dunwoody, and surrounding communities. We offer comprehensive medical weight loss programs featuring GLP-1 therapy as part of our integrated wellness practice.

What sets our Atlanta-based program apart is the full-spectrum approach. Many Atlanta clinics and telehealth services prescribe GLP-1 medications with minimal oversight. At Balanced, every patient receives comprehensive metabolic lab work, personalized medication selection, supportive peptide therapy for muscle preservation, nutritional guidance, and regular clinical monitoring.

We also offer the post-weight-loss aesthetic services that many patients want as their body transforms — body contouring, skin tightening, facial restoration — all under one roof. You don't need multiple providers across the city.

For patients outside Atlanta, we offer telehealth consultations with the same clinical depth. But if you're local, the in-person experience includes access to our full suite of regenerative wellness modalities (HBOT, red light therapy, BioCharger, PEMF) that complement the weight loss program.

Medical Weight Loss →  ·  About Us →